University Medical Center Groningen

BI, EFSD commit $3.3 million to European diabetes research initiatives

Friday, July 19, 2013

The Boehringer Ingelheim (BI) and European Foundation for the Study of Diabetes (EFSD) partnership has announced the recipients of its European-wide funding initiative targeted at diabetes research. Totaling $3.3 million, these are the first grants to be awarded as part of the EFSD/Boehringer Ingelheim European Diabetes Research Programs, which aim to stimulate and accelerate European research in diabetes.

[Read More]